BioMarin Pharmaceutical, Inc. (BMRN)
57.18
-1.26
(-2.16%)
USD |
NASDAQ |
Oct 02, 16:00
57.30
+0.12
(+0.21%)
After-Hours: 20:00
BioMarin Pharmaceutical Price : 57.18 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 58.52 | 58.73 | 57.15 | 57.18 | 2.193M |
| Oct 01, 2026 | 59.81 | 60.16 | 58.39 | 58.44 | 2.083M |
| Sep 30, 2026 | 59.90 | 60.70 | 59.37 | 60.00 | 1.798M |
| Sep 29, 2026 | 59.24 | 60.09 | 58.96 | 59.87 | 1.808M |
| Sep 28, 2026 | 59.87 | 60.07 | 58.74 | 59.46 | 2.358M |
| Sep 25, 2026 | 61.50 | 61.50 | 60.17 | 60.26 | 1.791M |
| Sep 24, 2026 | 62.21 | 62.33 | 61.12 | 61.35 | 1.659M |
| Sep 23, 2026 | 63.68 | 64.00 | 61.58 | 62.21 | 2.105M |
| Sep 22, 2026 | 64.34 | 64.79 | 63.35 | 63.37 | 1.963M |
| Sep 21, 2026 | 64.35 | 64.96 | 63.58 | 64.06 | 1.877M |
| Sep 18, 2026 | 65.25 | 65.29 | 63.84 | 63.94 | 4.456M |
| Sep 17, 2026 | 65.34 | 66.21 | 64.97 | 65.08 | 1.381M |
| Sep 16, 2026 | 64.48 | 65.67 | 64.34 | 64.73 | 2.253M |
| Sep 15, 2026 | 65.78 | 65.78 | 63.85 | 64.45 | 1.854M |
| Sep 14, 2026 | 66.27 | 66.88 | 65.72 | 66.41 | 1.336M |
| Sep 11, 2026 | 65.96 | 66.05 | 65.28 | 65.68 | 1.605M |
| Sep 10, 2026 | 64.41 | 65.59 | 63.57 | 65.51 | 2.203M |
| Sep 09, 2026 | 63.83 | 65.32 | 63.64 | 64.41 | 1.950M |
| Sep 08, 2026 | 65.24 | 66.26 | 64.01 | 64.63 | 1.458M |
| Sep 04, 2026 | 65.78 | 66.64 | 65.52 | 66.53 | 2.299M |
| Sep 03, 2026 | 67.30 | 67.70 | 66.32 | 66.43 | 1.478M |
| Sep 02, 2026 | 65.00 | 67.20 | 64.99 | 66.97 | 2.521M |
| Sep 01, 2026 | 65.54 | 66.02 | 64.49 | 64.84 | 1.782M |
| Aug 31, 2026 | 65.95 | 66.30 | 64.33 | 65.23 | 2.299M |
| Aug 28, 2026 | 64.99 | 65.08 | 64.07 | 64.66 | 1.098M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Alnylam Pharmaceuticals, Inc. | 219.72 |
| Vertex Pharmaceuticals, Inc. | 504.73 |
| Ascendis Pharma A/S | 227.87 |
| BridgeBio Pharma, Inc. | 67.25 |
| Incyte Corp. | 115.30 |
Price Related Metrics
| PE Ratio | 154.17 |
| PS Ratio | 3.211 |
| Price to Book Value | 1.750 |
| Price to Free Cash Flow | 15.31 |
| Earnings Yield | 0.65% |
| Market Cap | 11.07B |
| Operating PE Ratio | 17.35 |
| Normalized PE Ratio | 29.03 |